Patents by Inventor Kee Rang Park

Kee Rang Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR TREATING DIABETIC RETINOPATHY, COMPRISING RAAV CONTAINING SOLUBLE VEGFR-1 VARIANT CDNA
    Publication number: 20230024569
    Abstract: The present invention provides a pharmaceutical composition for treating diabetic retinopathy. According to the present invention, the pharmaceutical composition can treat diabetic retinopathy by means of a single administration and thus, compared to conventional treatment methods, which require intraocular injection on a monthly basis, can reduce pain and ocular damage and infections in patients and reduce treatment costs.
    Type: Application
    Filed: December 3, 2020
    Publication date: January 26, 2023
    Inventors: Steven Hyun Seung LEE, Kee Rang PARK, Young-lll LEE
  • Peptide aptamers against tenascin C
    Patent number: 9018351
    Abstract: The present invention relates to an anti-tenascin C peptide aptamer having a specific amino acid sequence and a diagnosis kit comprising it. The anti-tenascin C peptide aptamer of the instant invention shows a predominant clearance rate due to its small molecular weight as well as specific binding affinity to tenascin C, having excellent advantages in in vivo or ex vivo tumor imaging.
    Type: Grant
    Filed: July 31, 2013
    Date of Patent: April 28, 2015
    Assignee: Industry-Academy Cooperation Foundation, Dankook University
    Inventors: Sun Joo Jeong, Mee Young Kim, Ok Ran Kim, Heui Ran Lee, Kee Rang Park
  • PEPTIDE APTAMERS AGAINST TENASCIN C
    Publication number: 20140030736
    Abstract: The present invention relates to an anti-tenascin C peptide aptamer having a specific amino acid sequence and a diagnosis kit comprising it. The anti-tenascin C peptide aptamer of the instant invention shows a predominant clearance rate due to its small molecular weight as well as specific binding affinity to tenascin C, having excellent advantages in in vivo or ex vivo tumor imaging.
    Type: Application
    Filed: July 31, 2013
    Publication date: January 30, 2014
    Inventors: Sun Joo JEONG, Mee Young Kim, Ok Ran Kim, Heui Ran Lee, Kee Rang Park
  • Peptide Aptamers Against Tenascin C
    Publication number: 20100256334
    Abstract: The present invention relates to an anti-tenascin C peptide aptamer having a specific amino acid sequence and a diagnosis kit comprising it. The anti-tenascin C peptide aptamer of the instant invention shows a predominant clearance rate due to its small molecular weight as well as specific binding affinity to tenascin C, having excellent advantages in in vivo or ex vivo tumor imaging.
    Type: Application
    Filed: August 22, 2008
    Publication date: October 7, 2010
    Applicant: Industry-Academy Cooperation Foundation Dankook University
    Inventors: Sun Joo Jeong, Mee Young Kim, Ok Ran Kim, Heui Ran Lee, Kee Rang Park